brimonidine tartrate; brinzolamide · Alcon Labs Inc · NDA 204251
Simbrinza
Earliest generic entry, as listed
30 Oct 2030
Blocked by patent: US 9044484.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9044484 | drug product · sets the listed date | 30 Oct 2030 |
| US 9421265 | drug product | 17 Jun 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 204251 · 001 · RLD | suspension/drops, ophthalmic | 0.2%;1% | 30 Oct 2030 |